Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss

Summary

This double-blind placebo-controlled study will assess the tolerability, feasibility, and pharmacodynamics of intradermal Hair Stimulating Complex (HSC) in up to 18 of 27 women with Ludwig 1 or 2 classification or the Savin Frontal classification of hair loss. Safety measures include vital signs, dermatological examination of the scalp, pre- and post-dose blood and urine collection, as well as Investigator Global Assessments and subject self assessments throughout the 22-week study.

Timeline

Start

2018-07-02

Primary completion

2019-01-21

Completion

2021-01-21

Drugs

Indications